Literature DB >> 2387978

Effect of flubendazole on the number of first-stage larvae of Angiostrongylus cantonensis released in the faeces of treated rats.

J Maki1, T Yanagisawa.   

Abstract

The effect of flubendazole orally administered at 10 mg/kg/day for 5 consecutive days (the 11th, 20th or 40th post-infection) on the number of first-stage larvae (L1) of Angiostrongylus cantonensis released in the faeces of rats each infected with 40 third-stage larvae was determined. Faecal examination for 5 months, the period from medication to dissection of rats, showed that L1 release ceased in all the rats of medicated groups by about 1 week after the termination of dosing and resumed 1-2 months later in 86% of the rats which were dissected at the end of experiments with the recovery of adult worms of both sexes. Throughout the period of 5 months, about 2-4 x 10(4) L1/gram of fresh faeces was recorded in non-medicated control groups. There was a 38-79% reduction in adult worms at the dissection. Microscopic examination of the uteri of the remaining adult worms and lung tissues of rats confirmed no normal egg production in the adult worms from rats of medicated groups, except the rats with the resumption of faecal L1 release.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387978     DOI: 10.1017/s0022149x00011974

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  2 in total

1.  [Effect of the anthelminthic levamisole on the first-stage larva of Angiostrongylus cantonensis in infected rats].

Authors:  A Ishih
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

Review 2.  Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies.

Authors:  John Jacob; Argon Steel; Zhain Lin; Fiona Berger; Katrin Zöeller; Susan Jarvi
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.